Fundraising FoxPrecision Biologics
Rockville, US · Founded 2012 · Delaware corporation
Find your way into Precision Biologics
Sign up to see every warm intro you have to Precision Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Precision Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Precision Biologics develops therapeutic and diagnostic products for cancer patients. The company operates in the oncology biotech space in the United States.
Founders & leadership
RC
R.J. ChildressExecutive
PA
Philip ArlenExecutivePhilip Arlen is a board-certified medical oncologist who spent 11 years at the National Cancer Institute as director of the Clinical Research Group for the Laboratory of Tumor Immunology and Oncology, where he led cancer vaccine clinical trials. He is founder and CEO of Precision Biologics, which develops oncology therapeutics and diagnostics, and previously founded Neogenix Oncology; he holds multiple patents related to monoclonal antibodies targeting cancer that he developed.
AK
Albine K MartinExecutive
RA
Robert A WashingtonExecutive
Board
PS
Patrick Soon-ShiongBoard director
SB
Stanley B. Archibald, Jr.Board director
CZ
Christian ZapfBoard director
CK
Charles KimBoard director
MK
Mark KristenBoard director
SR
Severin RussoBoard director
SR
Sheldon RabinBoard director
CB
C. Brent HaggardBoard director
Reported raises · per SEC filings
Form D private placements$53.9M disclosed across 2 rounds · 2013–2015
▶$53.1MraisedOct 2015 · 34 investors · BiotechnologyRule 506(b)
▶$53.1MraisedOct 2015 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick Soon-ShiongDirector
- Stanley B. Archibald, Jr.Director, Promoter
- R.J. ChildressExecutive Officer
- Christian ZapfDirector
- Charles KimDirector
- Philip M. ArlenExecutive Officer, Director
- Offering amount
- $53.1M
- Amount sold
- $53.1M
- Minimum investment
- $50K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$795KraisedApr 2014 · 11 investors · BiotechnologyRule 506(b)
▶$795KraisedApr 2014 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- R.J. ChildressExecutive Officer
- Mark KristenDirector
- Severin RussoDirector
- Sheldon RabinDirector
- Stanley B Archibald, Jr.Director, Promoter
- Albine K MartinExecutive Officer
- Robert A WashingtonExecutive Officer
- Philip M ArlenExecutive Officer
- C. Brent HaggardDirector
- Offering amount
- $2.4M
- Amount sold
- $795K
- Minimum investment
- $60K
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Precision For MedicinePrecision for Medicine is a contract research organization that provides clinical trial management and regulatory support for drug development programs, including oncology, hematology, cell and gene therapy, CAR-T, and radiopharmaceutical trials. It serves pharmaceutical and biotech sponsors running multinational Phase I–IV studies.
Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Precision Medicine Group, Inc.Precision Medicine Group provides biomarker-driven research and development services and commercialization support for pharmaceutical and life science companies across drug development, manufacturing, and market access.
Companies working in the same space as Precision Biologics.
Frequently asked questions
- What does Precision Biologics do?
- Precision Biologics develops therapeutic and diagnostic products for cancer patients. The company operates in the oncology biotech space in the United States.
- How much funding has Precision Biologics raised?
- Precision Biologics has disclosed $53.9M raised across 2 rounds.
- Where is Precision Biologics headquartered?
- Precision Biologics is headquartered in Rockville, US.